Minimally invasive anti-ageing treatments that do not require any penetration into the skin. Non-invasive procedures cover a number of diagnostic and therapeutic procedures, such as chiropractic manipulation, physical therapy, and heat therapy. Minimally invasive treatments refer to a range of procedures that involve tiny injections and exclude any surgical invasion into the human body. The most common treatments are injections with botulinum toxin (Botox), dermal fillers, lipofilling, and microdermabrasion (non-chemical). Lasers, chemical peels and facials, and cosmeceuticals (a combination of cosmetics and pharmaceuticals) are also considered as minimally invasive treatments. Botax remains mainstay for minimally invasive or non-invasive anti-ageing treatment or procedure in various geographies.
Minimally Invasive Anti-Ageing Treatment Market: Drivers and Restraints
Global minimally invasive anti-ageing treatment market is expected to grow at significant rate owing to lesser cost of treatment than high tech devices, effective and affordable alternative to plastic surgery procedures. The factors currently contributing to the revenue growth of the minimally invasive anti-ageing treatment market is requirement of little to no downtime for these procedures and minimally invasive treatments require very small incisions or injections sites, resulting in less pain and very few post-procedure complications. Furthermore, emerging middle class and rapidly aging world population are expected to drive the market for minimally invasive anti-ageing treatment over the forecast period.
Global minimally invasive anti-ageing treatment market may hinder owing to non-permanent nature of these treatments which requires re-treatment in given specific period of time which is expected to affect the market negatively over the forecast period. The minimally invasive anti-ageing treatment market may restrained by side effects associated with treatment such as mild swelling and bleeding, and occasional skin imperfections which are expected to hinder market revenue growth over the forecast period
Minimally Invasive Anti-Ageing Treatment Market: Segmentation
Global minimally invasive anti-ageing treatment market has been segmented on the basis of treatment type, route of administration, distribution channel, and region
Based on the treatment type, the global minimally invasive anti-ageing treatment market is segmented into the following:
Laser Hair Removal
Based on the route of administration, the global minimally invasive anti-ageing treatment market is segmented into the following:
Based on the distribution channel, the global minimally invasive anti-ageing treatment market is segmented into the following:
Minimally Invasive Anti-Ageing Treatment Market: Overview
Global minimally invasive anti-ageing treatment market is witnessing significant changes due to rising uptake of combination treatments across the globe. Rising number of dermatology clinics in Asia Pacific and Latin America region and increasing access to products and services owing to OTC formulations in the market expected create significant market changes over the forecast period.
Minimally Invasive Anti-Ageing Treatment Market: Region-wise Outlook
Geographically, minimally invasive anti-ageing treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Western Europe will remain key markets for Minimally Invasive Anti-Ageing Treatment products due to increased awareness among key stakeholders, rising preference for aesthetics, and increasing affordability and innovation all these factors together helps to maintain larger market revenue share in the global minimally invasive anti-ageing treatment market by these regions. Asia Pacific is anticipated to present better growth opportunity owing to availability of large addressable population and favourable demographic dividend in the region.
Minimally Invasive Anti-Ageing Treatment Market: Key Players
Some of the players in the global Minimally Invasive Anti-Ageing Treatment Market are Galderma S.A., Allergan Plc., Johnson & Johnson Services, Inc., Valeant Pharmaceuticals International, Inc., Alma Lasers Ltd., Lumenis Ltd., Merz Pharma GmbH & Co. KGaA,, Cutera, Inc., Syneron Medical Ltd. to name a few.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Value chain and stakeholder analysis
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Minimally Invasive Anti-Ageing Treatment Market during 2017– 2027
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453